Agency Information Collection Activities: Proposed Collection; Public Comment Request; Application and Other Forms Used by the National Health Service Corps Scholarship Program, the NHSC Students to Service Loan Repayment Program, and the Native Hawaiian Health Scholarship Program, 27902-27904 [2023-09356]
Download as PDF
<![CDATA[
lotter on DSK11XQN23PROD with NOTICES1
27902
Federal Register / Vol. 88, No. 85 / Wednesday, May 3, 2023 / Notices
the subject of NDA 021400, held by
Bayer HealthCare Pharmaceuticals, Inc.,
and initially approved on August 19,
2003. Levitra is a phosphodiesterase 5
inhibitor indicated for the treatment of
erectile dysfunction.
In letters dated September 26, 2019,
September 24, 2020, and September 20,
2021, Bayer HealthCare
Pharmaceuticals, Inc. notified FDA that
Levitra (vardenafil hydrochloride) oral
tablets, 5 mg, 10 mg and 20 mg,
respectively, were being discontinued,
and FDA moved the drug products to
the ‘‘Discontinued Drug Product List’’
section of the Orange Book.
Respira Therapeutics, Inc. submitted a
citizen petition dated August 29, 2022
(Docket No. FDA–2022–P–2060), under
21 CFR 10.30, requesting that the
Agency determine whether Levitra
(vardenafil hydrochloride) oral tablets,
20 mg, were withdrawn from sale for
reasons of safety or effectiveness.
Although the citizen petition did not
address the 5 mg and 10 mg strengths,
those strengths have also been
discontinued. On our own initiative, we
have also determined whether those
strengths were withdrawn for safety or
effectiveness reasons.
After considering the citizen petition
and reviewing Agency records and
based on the information we have at this
time, FDA has determined under
§ 314.161 that Levitra (vardenafil
hydrochloride) oral tablets, 5 mg, 10 mg,
and 20 mg, were not withdrawn for
reasons of safety or effectiveness. The
petitioner has identified no data or other
information suggesting that these drug
products were withdrawn for reasons of
safety or effectiveness. We have
carefully reviewed our files for records
concerning the withdrawal of Levitra
(vardenafil hydrochloride) oral tablets, 5
mg, 10 mg, and 20 mg, from sale. We
have also independently evaluated
relevant literature and data for possible
postmarketing adverse events. We have
reviewed the available evidence and
determined that these drug products
were not withdrawn from sale for
reasons of safety or effectiveness.
Accordingly, the Agency will
continue to list Levitra (vardenafil
hydrochloride) oral tablets, 5 mg, 10 mg,
and 20 mg, in the ‘‘Discontinued Drug
Product List’’ section of the Orange
Book. The ‘‘Discontinued Drug Product
List’’ delineates, among other items,
drug products that have been
discontinued from marketing for reasons
other than safety or effectiveness. FDA
will not begin procedures to withdraw
approval of approved ANDAs that refer
to these drug products. Additional
ANDAs for these drug products may
also be approved by the Agency as long
VerDate Sep<11>2014
18:32 May 02, 2023
Jkt 259001
as they meet all other legal and
regulatory requirements for the approval
of ANDAs. If FDA determines that
labeling for these drug products should
be revised to meet current standards, the
Agency will advise ANDA applicants to
submit such labeling.
Dated: April 28, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023–09365 Filed 5–2–23; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection; Public
Comment Request; Application and
Other Forms Used by the National
Health Service Corps Scholarship
Program, the NHSC Students to
Service Loan Repayment Program, and
the Native Hawaiian Health
Scholarship Program
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In compliance with the
Paperwork Reduction Act of 1995,
HRSA submitted an Information
Collection Request (ICR) to the Office of
Management and Budget (OMB) for
review and approval. Comments
submitted during the first public review
of this ICR will be provided to OMB.
OMB will accept further comments from
the public during the review and
approval period. OMB may act on
HRSA’s ICR only after the 30-day
comment period for this notice has
closed.
SUMMARY:
Comments on this ICR should be
received no later than June 2, 2023.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under Review—Open for
Public Comments,’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request a copy of the clearance requests
submitted to OMB for review, email
Samantha Miller, the Acting HRSA
Information Collection Clearance
Officer, at paperwork@hrsa.gov or call
301–594–4394.
DATES:
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
SUPPLEMENTARY INFORMATION:
Information Collection Request Title:
Application and Other Forms Used by
the National Health Service Corps
(NHSC) Scholarship Program (SP), the
NHSC Students to Service Loan
Repayment Program (S2S LRP), and the
Native Hawaiian Health Scholarship
Program (NHHSP), OMB No. 0915–
0146-Revision.
Abstract: Administered by HRSA’s
Bureau of Health Workforce, the NHSC
SP, NHSC S2S LRP, and the NHHSP
provide scholarships or loan repayment
to qualified students who are pursuing
primary care health professions
education and training. In return,
students agree to provide primary health
care services in underserved
communities located in federally
designated Health Professional Shortage
Areas once they are fully trained and
licensed health professionals. Awards
are made to applicants who demonstrate
the greatest potential for successful
completion of their education and
training as well as commitment to
provide primary health care services to
communities of greatest need. The
information from program applications,
forms, and supporting documentation is
used to select the best qualified
candidates for these competitive
awards, and to monitor program
participants’ enrollment in school,
postgraduate training, and compliance
with program requirements.
Although some program forms vary
from program to program (see programspecific burden charts below), required
forms generally include: a program
application, academic and nonacademic letters of recommendation, the
authorization to release information,
and the acceptance/verification of good
academic standing report. The NHHSP
is not seeking to change or add any
forms or documentation.
A 60-day notice published in the
Federal Register on February 14, 2023,
88 FR 9525–26. There were no public
comments.
Need and Proposed Use of the
Information: The NHSC SP, S2S LRP,
and NHHSP applications, forms, and
supporting documentation are used to
collect necessary information from
applicants and schools that enable
HRSA to make selection determinations
for the competitive awards and monitor
compliance (via training programs and
sites) with program requirements.
Likely Respondents: Qualified
students who are pursuing education
and training in primary care health
professions and are interested in
working in health professional shortage
areas and schools at which such
students are enrolled.
E:\FR\FM\03MYN1.SGM
03MYN1
27903
Federal Register / Vol. 88, No. 85 / Wednesday, May 3, 2023 / Notices
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose, or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating, and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
Total Estimated Annualized Burden—
Hours
NHSC SCHOLARSHIP PROGRAM APPLICATION
Number of
respondents
Form name
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total
responses
Total
burden
hours
NHSC Scholarship Program Application .............................
Letters of Recommendation .................................................
Authorization to Release Information ..................................
Acceptance/Verification of Good Standing Report ..............
Verification of Disadvantaged Background Status ..............
2,575
2,575
2,575
2,575
615
1
2
1
1
1
2,575
5,150
2,575
2,575
615
2.00
1.00
.10
.25
.25
5150.00
5150.00
257.50
643.75
153.75
Total ..............................................................................
* 2,575
........................
13,490
........................
11,355.00
* Certain documents are submitted by a subset of respondents consistent with program requirements.
NHSC AWARDEES/SCHOOLS/POST GRADUATE TRAINING PROGRAMS/SITES
Number of
respondents
Form name
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total
responses
Total
burden
hours
Data Collection Worksheet ..................................................
Post Graduate Training Verification Form ...........................
Enrollment Verification Form ...............................................
400
100
600
1
1
2
400
100
1,200
1.00
.50
.50
400
50
600
Total ..............................................................................
* 600
........................
1,700
........................
1,050
* Please note that the same group of respondents may complete each form as necessary.
NHSC STUDENTS TO SERVICE LOAN REPAYMENT PROGRAM APPLICATION
Number of
respondents
Form name
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total
responses
Total
burden
hours
NHSC Students to Service Loan Repayment Program Application ............................................................................
Letters of Recommendation .................................................
Authorization to Release Information ..................................
Acceptance/Verification of Good Standing Report ..............
Verification of Disadvantaged Background Status ..............
284
284
284
284
84
1
1
1
1
1
284
284
284
284
84
2.00
2.00
.10
.25
.25
568.00
568.00
28.40
71.00
21.00
Total ..............................................................................
* 284
........................
1,220
........................
1,256.40
* Certain documents are submitted by a subset of respondents consistent with program requirements.
NATIVE HAWAIIAN HEALTH SCHOLARSHIP PROGRAM APPLICATION
Number of
respondents
lotter on DSK11XQN23PROD with NOTICES1
Form name
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total
Responses
Total
burden
hours
Native Hawaiian Health Scholarship Program Application ..
Letters of Recommendation .................................................
Authorization to Release Information ..................................
Acceptance/Verification of Good Standing Report ..............
Scholar Enrollment Verification Form ..................................
Change in Program Curriculum Form .................................
NHHSP Graduation Documentation Form ...........................
310
310
310
40
40
40
40
1.00
2.00
1.00
1.00
7.50
2.00
1.00
310
620
310
40
300
80
40
2.00
.25
.25
.25
.50
.25
.25
620.00
155.00
77.50
10.00
150.00
20.00
10.00
Total ..............................................................................
* 310
........................
1,700
........................
1,042.50
* Certain documents are submitted by a subset of respondents consistent with program requirements.
VerDate Sep<11>2014
18:32 May 02, 2023
Jkt 259001
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
E:\FR\FM\03MYN1.SGM
03MYN1
27904
Federal Register / Vol. 88, No. 85 / Wednesday, May 3, 2023 / Notices
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023–09356 Filed 5–2–23; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Findings of Research Misconduct
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
Findings of research
misconduct have been made against
Johnny J. He, Ph.D. (Respondent), who
is a Professor, Department of
Microbiology and Immunology,
Rosalind Franklin University of
Medicine and Science (RFUMS).
Respondent engaged in research
misconduct in research reported in
grant applications submitted for U.S.
Public Health Service (PHS) funds,
specifically U01 DA056010–01 and DP1
DA056160–01 submitted to the National
Institute on Drug Abuse (NIDA),
National Institutes of Health (NIH), R01
AG078019–01 submitted to the National
Institute on Aging (NIA), NIH, and R35
NS127233–01 submitted to the National
Institute of Neurological Disorders and
Stroke (NINDS), NIH. The
administrative actions, including
supervision for a period of three (3)
years, were implemented beginning on
April 17, 2023, and are detailed below.
FOR FURTHER INFORMATION CONTACT:
Sheila Garrity, JD, MPH, MBA, Director,
Office of Research Integrity, 1101
Wootton Parkway, Suite 240, Rockville,
MD 20852, (240) 453–8200.
SUPPLEMENTARY INFORMATION: Notice is
hereby given that the Office of Research
Integrity (ORI) has taken final action in
the following case:
Johnny J. He, Ph.D., Rosalind Franklin
University of Medicine and Science:
Based on the report of an investigation
conducted by RFUMS, an admission by
Respondent, and analysis conducted by
ORI in its oversight review, ORI found
that Johnny J. He, Ph.D., Professor,
Department of Microbiology and
Immunology, RFUMS, engaged in
research misconduct in research
reported in grant applications submitted
for PHS funds, specifically U01
DA056010–01 and DP1 DA056160–01
submitted to NIDA, NIH, R01
AG078019–01 submitted to NIA, NIH,
and R35 NS127233–01 submitted to
NINDS, NIH.
ORI found that Respondent engaged
in research misconduct by intentionally,
knowingly, or recklessly falsifying,
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:32 May 02, 2023
Jkt 259001
fabricating, and plagiarizing
experimental data and text that
described the research from one (1) preprint and four (4) published papers and
represented the data and/or ideas as his
own under different experimental
conditions in four (4) NIH grant
applications and in one research record.
The falsified, fabricated, and plagiarized
research data and text appeared in the
following NIH grant applications:
• NIA, NIH, grant R01 AG078019–01,
‘‘iTat mice to model HIV-impaired
neurogenesis and accelerated aging,’’
submitted on September 7, 2021
• NIDA, NIH, grant U01 DA056010–01,
‘‘Single cell and spatial
transcriptomic changes of cocaine use
in the iTat HAND model,’’ submitted
on July 20, 2021
• NIDA, NIH, grant DP1 DA056160–01,
‘‘Targeting epigenetic changes to
understand and treat CUD in people
living with HAND,’’ submitted on
August 13, 2021
• NINDS, NIH, grant R35 NS127233–01,
‘‘HIV-associated neurocognitive
disorder: from mechanisms to
therapeutics,’’ submitted on July 13,
2021
The sources of the plagiarized images
and text were:
• Clin Transl Med. 2017 June 8;6(1):20.
doi: 10.1186/s40169–017–0150–9
(hereafter referred to as ‘‘Clin Trans
Med 2017’’)
• Sci Adv. 2019 October
16;5(10):eaax1532. doi: 10.1126/
sciadv.aax1532 (hereafter referred to
as ‘‘Sci Adv 2019’’)
• BioRxiv. March 5, 2020. doi:10.1101/
2020.02.29.970558v2 (hereafter
referred to as ‘‘BioRxiv 2020’’).
BioRxiv 2020 is a preprint version of
Nature. 2021 October
6;598(7879):103–110. doi: 10.1038/
s41586–021–03500–8
• Biosci Biotechnol Biochem. 2020
May;84(5):919–926. doi:10.1080/
09168451.2020.1714420 (hereafter
referred to as ‘‘BBB 2020’’)
• Front Oncol. 2021 January
19;10:607349. doi: 10.3389/
fonc.2020.607349 (hereafter referred
to as ‘‘Front Onc 2021’’)
Specifically, ORI found that
Respondent knowingly, intentionally, or
recklessly:
• falsified, fabricated, and plagiarized
research data and the text that described
the research by:
—using Figures 1A and 1B of BBB 2020,
representing wild-type and APP23
mice at 6 and 24 months, as the
Respondent’s own data in Figures 5A
and 5B of U01 DA056010–01 and
Figures 7A and 7B of R01 AG78019–
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
01, representing wild-type and iTat
mice at 6 and 12 months
—using Figures 3c and 3d of BioRxiv
2020, representing results in 60 days
old Snap25–IRES2–Cre mice crossed
to Ai14 mice, as the Respondent’s
own data in Figure 6 of U01
DA056010–01 and Figure 8 of R01
AG078019–01, representing results in
12-weeks old iTat mice
—using, cropping, and splicing Figures
5g–5i of BioRxiv 2020, representing
cell type transcription factors
networks signature of the regulatory
genome in neurons isolated from the
brains of Snap25–IRES2–Cre mice
crossed to Ai14 mice, as the
Respondent’s own data in one
research record intended for use in
preparing figures for incorporation in
U01 DA056010–01, representing
spatiotemporal atlas of gene
regulatory networks and biological
pathways in the brain during
neurogenesis and aging altered by Tat
expression and HIV infection
• fabricated and plagiarized research
data and text that described the research
by:
—using Figure 3 of Front Onc 2021 as
the Respondent’s own data in Figure
8 of U01 DA056010–01 and Figure 10
of R01 AG078019–01
• plagiarized text by:
—using a paragraph from Sci Adv 2019
as the Respondent’s own text
describing cocaine use disorder in the
section titled ‘‘The problem
description and a new therapeutic
strategy for CUD in people living with
HAND’’ of DP1 DA056160–01
—using a paragraph from Clin Trans
Med 2017 as the Respondent’s own
text describing single cell sequencing
in Specific Aim 2 of both U01
DA056010–01 and R01 AG078019–01
Dr. He entered into a Voluntary
Settlement Agreement (Agreement) and
voluntarily agreed to the following:
(1) Respondent will have his research
supervised for a period of three (3) years
beginning on April 17, 2023 (the
‘‘Supervision Period’’). Prior to the
submission of an application for PHS
support for a research project on which
Respondent’s participation is proposed
and prior to Respondent’s participation
in any capacity in PHS-supported
research, Respondent will submit a plan
for supervision of Respondent’s duties
to ORI for approval. The supervision
plan must be designed to ensure the
integrity of Respondent’s research.
Respondent will not participate in any
PHS-supported research until such a
supervision plan is approved by ORI.
Respondent will comply with the
agreed-upon supervision plan.
E:\FR\FM\03MYN1.SGM
03MYN1
]]>Agencies
[Federal Register Volume 88, Number 85 (Wednesday, May 3, 2023)]
[Notices]
[Pages 27902-27904]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-09356]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities: Proposed Collection;
Public Comment Request; Application and Other Forms Used by the
National Health Service Corps Scholarship Program, the NHSC Students to
Service Loan Repayment Program, and the Native Hawaiian Health
Scholarship Program
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the Paperwork Reduction Act of 1995, HRSA
submitted an Information Collection Request (ICR) to the Office of
Management and Budget (OMB) for review and approval. Comments submitted
during the first public review of this ICR will be provided to OMB. OMB
will accept further comments from the public during the review and
approval period. OMB may act on HRSA's ICR only after the 30-day
comment period for this notice has closed.
DATES: Comments on this ICR should be received no later than June 2,
2023.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under Review--Open for
Public Comments,'' or by using the search function.
FOR FURTHER INFORMATION CONTACT: To request a copy of the clearance
requests submitted to OMB for review, email Samantha Miller, the Acting
HRSA Information Collection Clearance Officer, at [email protected] or
call 301-594-4394.
SUPPLEMENTARY INFORMATION: Information Collection Request Title:
Application and Other Forms Used by the National Health Service Corps
(NHSC) Scholarship Program (SP), the NHSC Students to Service Loan
Repayment Program (S2S LRP), and the Native Hawaiian Health Scholarship
Program (NHHSP), OMB No. 0915-0146-Revision.
Abstract: Administered by HRSA's Bureau of Health Workforce, the
NHSC SP, NHSC S2S LRP, and the NHHSP provide scholarships or loan
repayment to qualified students who are pursuing primary care health
professions education and training. In return, students agree to
provide primary health care services in underserved communities located
in federally designated Health Professional Shortage Areas once they
are fully trained and licensed health professionals. Awards are made to
applicants who demonstrate the greatest potential for successful
completion of their education and training as well as commitment to
provide primary health care services to communities of greatest need.
The information from program applications, forms, and supporting
documentation is used to select the best qualified candidates for these
competitive awards, and to monitor program participants' enrollment in
school, postgraduate training, and compliance with program
requirements.
Although some program forms vary from program to program (see
program-specific burden charts below), required forms generally
include: a program application, academic and non-academic letters of
recommendation, the authorization to release information, and the
acceptance/verification of good academic standing report. The NHHSP is
not seeking to change or add any forms or documentation.
A 60-day notice published in the Federal Register on February 14,
2023, 88 FR 9525-26. There were no public comments.
Need and Proposed Use of the Information: The NHSC SP, S2S LRP, and
NHHSP applications, forms, and supporting documentation are used to
collect necessary information from applicants and schools that enable
HRSA to make selection determinations for the competitive awards and
monitor compliance (via training programs and sites) with program
requirements.
Likely Respondents: Qualified students who are pursuing education
and training in primary care health professions and are interested in
working in health professional shortage areas and schools at which such
students are enrolled.
[[Page 27903]]
Burden Statement: Burden in this context means the time expended by
persons to generate, maintain, retain, disclose, or provide the
information requested. This includes the time needed to review
instructions; to develop, acquire, install, and utilize technology and
systems for the purpose of collecting, validating, and verifying
information, processing and maintaining information, and disclosing and
providing information; to train personnel and to be able to respond to
a collection of information; to search data sources; to complete and
review the collection of information; and to transmit or otherwise
disclose the information. The total annual burden hours estimated for
this ICR are summarized in the table below.
Total Estimated Annualized Burden--Hours
NHSC Scholarship Program Application
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of Total burden per Total burden
Form name respondents responses per responses response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
NHSC Scholarship Program 2,575 1 2,575 2.00 5150.00
Application....................
Letters of Recommendation....... 2,575 2 5,150 1.00 5150.00
Authorization to Release 2,575 1 2,575 .10 257.50
Information....................
Acceptance/Verification of Good 2,575 1 2,575 .25 643.75
Standing Report................
Verification of Disadvantaged 615 1 615 .25 153.75
Background Status..............
-------------------------------------------------------------------------------
Total....................... * 2,575 .............. 13,490 .............. 11,355.00
----------------------------------------------------------------------------------------------------------------
* Certain documents are submitted by a subset of respondents consistent with program requirements.
NHSC Awardees/Schools/Post Graduate Training Programs/Sites
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Form name Number of responses per Total per response Total burden
respondents respondent responses (in hours) hours
----------------------------------------------------------------------------------------------------------------
Data Collection Worksheet....... 400 1 400 1.00 400
Post Graduate Training 100 1 100 .50 50
Verification Form..............
Enrollment Verification Form.... 600 2 1,200 .50 600
-------------------------------------------------------------------------------
Total....................... * 600 .............. 1,700 .............. 1,050
----------------------------------------------------------------------------------------------------------------
* Please note that the same group of respondents may complete each form as necessary.
NHSC Students to Service Loan Repayment Program Application
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Form name Number of responses per Total per response Total burden
respondents respondent responses (in hours) hours
----------------------------------------------------------------------------------------------------------------
NHSC Students to Service Loan 284 1 284 2.00 568.00
Repayment Program Application..
Letters of Recommendation....... 284 1 284 2.00 568.00
Authorization to Release 284 1 284 .10 28.40
Information....................
Acceptance/Verification of Good 284 1 284 .25 71.00
Standing Report................
Verification of Disadvantaged 84 1 84 .25 21.00
Background Status..............
-------------------------------------------------------------------------------
Total....................... * 284 .............. 1,220 .............. 1,256.40
----------------------------------------------------------------------------------------------------------------
* Certain documents are submitted by a subset of respondents consistent with program requirements.
Native Hawaiian Health Scholarship Program Application
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Form name Number of responses per Total per response Total burden
respondents respondent Responses (in hours) hours
----------------------------------------------------------------------------------------------------------------
Native Hawaiian Health 310 1.00 310 2.00 620.00
Scholarship Program Application
Letters of Recommendation....... 310 2.00 620 .25 155.00
Authorization to Release 310 1.00 310 .25 77.50
Information....................
Acceptance/Verification of Good 40 1.00 40 .25 10.00
Standing Report................
Scholar Enrollment Verification 40 7.50 300 .50 150.00
Form...........................
Change in Program Curriculum 40 2.00 80 .25 20.00
Form...........................
NHHSP Graduation Documentation 40 1.00 40 .25 10.00
Form...........................
-------------------------------------------------------------------------------
Total....................... * 310 .............. 1,700 .............. 1,042.50
----------------------------------------------------------------------------------------------------------------
* Certain documents are submitted by a subset of respondents consistent with program requirements.
[[Page 27904]]
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023-09356 Filed 5-2-23; 8:45 am]
BILLING CODE 4165-15-P
